{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT06434402",
            "orgStudyIdInfo": {
                "id": "2024-0440"
            },
            "secondaryIdInfos": [
                {
                    "id": "NCI-2024-04531",
                    "type": "OTHER",
                    "domain": "NCI-CTRP Clinical Registry"
                }
            ],
            "organization": {
                "fullName": "M.D. Anderson Cancer Center",
                "class": "OTHER"
            },
            "briefTitle": "A Virtual, Group-Based, Expressive Writing Intervention for Survivors of Adolescent and Young Adult Cancer",
            "officialTitle": "A Virtual, Group-Based, Expressive Writing Intervention for Survivors of Adolescent and Young Adult Cancer",
            "therapeuticArea": [
                "Oncology and Hematology"
            ],
            "study": "a-virtual-group-based-expressive-writing-intervention-for-survivors-of-adolescent-and-young-adult-cancer"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-06",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2024-05-22",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2026-09-01",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2026-09-01",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2024-05-21",
            "studyFirstSubmitQcDate": "2024-05-23",
            "studyFirstPostDateStruct": {
                "date": "2024-05-30",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-06-10",
            "lastUpdatePostDateStruct": {
                "date": "2024-06-13",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "M.D. Anderson Cancer Center",
                "class": "OTHER"
            },
            "collaborators": [
                {
                    "name": "National Cancer Institute (NCI)",
                    "class": "NIH"
                }
            ]
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": false,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "To learn more about the experiences of adolescent and young adult cancer survivors and investigate whether a group-based writing intervention can help to improve quality of life of adolescent and young adult cancer survivors.",
            "detailedDescription": "Primary Objective:\n\nTo evaluate the feasibility of a virtual, group-based expressive writing intervention for survivors of adolescent and young adult cancer.\n\nSecondary Objective:\n\nTo preliminarily assess the impact of the study for cancer survivors."
        },
        "conditionsModule": {
            "conditions": [
                "Cancer"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "NA"
            ],
            "designInfo": {
                "allocation": "NON_RANDOMIZED",
                "interventionModel": "SINGLE_GROUP",
                "primaryPurpose": "SUPPORTIVE_CARE",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 30,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Emerging adults (ages18-25 years)",
                    "type": "EXPERIMENTAL",
                    "description": "Participants complete questionnaires over 20 minutes about their mood, health, and demographic information at baseline, and 1, and 3 months.\n\nParticipants are asked to write about their cancer experiences over 20 minutes (non-stop) for 4 weeks.",
                    "interventionNames": [
                        "Behavioral: Behavioral Intervention"
                    ]
                },
                {
                    "label": "Young adults (ages 26-39 years)",
                    "type": "EXPERIMENTAL",
                    "description": "Participants complete questionnaires over 20 minutes about their mood, health, and demographic information at baseline, and 1, and 3 months.\n\nParticipants are asked to write about their cancer experiences over 20 minutes (non-stop) for 4 weeks.",
                    "interventionNames": [
                        "Behavioral: Behavioral Intervention"
                    ]
                },
                {
                    "label": "General group (ages 18-39 years)",
                    "type": "EXPERIMENTAL",
                    "description": "Participants complete questionnaires over 20 minutes about their mood, health, and demographic information at baseline, and 1, and 3 months.\n\nParticipants are asked to write about their cancer experiences over 20 minutes (non-stop) for 4 weeks.",
                    "interventionNames": [
                        "Behavioral: Behavioral Intervention"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "BEHAVIORAL",
                    "name": "Behavioral Intervention",
                    "description": "Write about cancer experiences",
                    "armGroupLabels": [
                        "Emerging adults (ages18-25 years)",
                        "General group (ages 18-39 years)",
                        "Young adults (ages 26-39 years)"
                    ],
                    "otherNames": [
                        "Behavior Condition Therapy",
                        "Behavior Modification",
                        "Behavior or Life Style Modifications",
                        "Behavior Therapy",
                        "Behavioral Treatment"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Study Completion Rate",
                    "description": "The Study completion rate is defined as the average proportion of participants who complete follow-up assessments at 1-month follow-up. We will also calculate the 95% confidence intervals for the study completion rate.",
                    "timeFrame": "At 1 month follow-up"
                },
                {
                    "measure": "Intervention Adherence Rate",
                    "description": "The intervention adherence rate will be calculated as the number of completed writing tasks divided by the total number of assigned tasks (4).",
                    "timeFrame": "At the end of intervention (week 8)"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Functional Assessment of Cancer Therapy-General",
                    "description": "The Functional Assessment of Cancer Therapy-General will be used to measure multidimensional quality of life, encompassing physical, social, emotional, and functional well-being, across 27 items. Each item is rated on a 5-point Likert scale ranging from 0 to 4. The overall score can range from 0 to 108, with higher scores indicating a better quality of life.",
                    "timeFrame": "Baseline, and 1- and 3-month follow-up"
                },
                {
                    "measure": "Perceived Stress",
                    "description": "The Perceived Stress scale will be used to measure perceived stress. This 4-item measure assesses the degree to which situations in one's life are appraised as stressful. The overall score can range from 0 to 16, with higher scores indicating higher perceived stress.",
                    "timeFrame": "Baseline, and 1- and 3-month follow-up"
                },
                {
                    "measure": "Coping self-efficacy",
                    "description": "The Cancer Behavior Inventory will be used to measure self-efficacy for coping with cancer. Each item is rated on a 9-point Likert scale. The total score ranges from 9 to 81, with higher scores indicating greater self-efficacy for coping with cancer.",
                    "timeFrame": "Baseline, and 1- and 3-month follow-up"
                },
                {
                    "measure": "Impact of Event Scale",
                    "description": "The 5-item intrusion subscale of the Impact of Event Scale will be used to assess unwanted thoughts related to cancer. Each item is rated on a 4-point Likert scale. The total score ranges from 0 to 25, with higher scores indicating a greater frequency and intensity of intrusive thoughts.",
                    "timeFrame": "Baseline, and 1- and 3-month follow-up"
                },
                {
                    "measure": "Common Humanity & Self-Kindness",
                    "description": "Common Humanity and Self-Kindness will be measured using the subscales of the Self-Compassion Scale. These subscales capture positive aspects of self-compassion, including self-kindness (e.g., \"When I am going through a very hard time, I give myself the caring and tenderness I need\") and common humanity (e.g., \"When I am down and out, I remind myself that there are lots of other people in the world feeling like me\"). Each item is rated on a 5-point Likert scale. The total score for each subscale ranges from 5 to 25, with higher scores indicating a stronger sense of common humanity and self-kindness.",
                    "timeFrame": "Baseline, and 1- and 3-month follow-up"
                },
                {
                    "measure": "Posttraumatic growth",
                    "description": "The Posttraumatic Growth Inventory will be used to assess perceived positive changes as a result of a specific traumatic event. It includes 9 items, each rated on a 6-point Likert scale. The total score ranges from 0 to 45, with higher scores indicating greater perceived posttraumatic growth.",
                    "timeFrame": "Baseline, and 1- and 3-month follow-up"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion criteria:\n\n* Age 15-39 years at cancer diagnosis\n* Age 18-39 years at study entry\n* Within 5 years of diagnosis of stage II-IV cancer\n* Completed active treatment (participants receiving maintenance therapy remain eligible)\n* No evidence of disease\n* Can speak, read, and write in English.\n\nExclusion criteria:\n\n* Nonmelanoma skin cancer\n* Major mental health disorder (e.g., schizophrenia or bipolar disorder \\[determined from patient records or self-disclosure\\])\n* No internet access.",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "maximumAge": "39 Years",
            "stdAges": [
                "ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Qian Lu, MD,PHD",
                    "role": "CONTACT",
                    "phone": "(713) 745-8324",
                    "email": "qlu@mdanderson.org"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Qian Lu, MD,PHD",
                    "affiliation": "M.D. Anderson Cancer Center",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "MD Anderson Cancer Center",
                    "status": "RECRUITING",
                    "city": "Houston",
                    "state": "Texas",
                    "zip": "77030",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Qian Lu, MD,PHD",
                            "role": "CONTACT",
                            "phone": "713-745-8324",
                            "email": "qlu@mdanderson.org"
                        },
                        {
                            "name": "Qian Lu, MD,PHD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 29.76328,
                        "lon": -95.36327
                    }
                }
            ]
        },
        "referencesModule": {
            "seeAlsoLinks": [
                {
                    "label": "MD Anderson Cancer Center",
                    "url": "http://www.mdanderson.org"
                }
            ]
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        }
    },
    "hasResults": false
}